Swarthmore Group Inc Abbott Laboratories Transaction History

Swarthmore Group Inc

$249 Million
Q2 2022

A detailed history of Swarthmore Group Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Swarthmore Group Inc holds 2,581 shares of ABT stock, worth $266,359. This represents 0.11% of its overall portfolio holdings.

Number of Shares

2,581

Previous 44,061 94.14%

Holding current value

$266,359

Previous $5.22 Million 94.63%

% of portfolio

0.11%

Previous 1.33%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$102.07 - $123.37 $4.23 Million - $5.12 Million	-41,480 Reduced 94.14%	2,581 $280,000
Q1 2022 Apr 11, 2022	SELL	$114.02 - $139.04 $51,423 - $62,707	-451 Reduced 1.01%	44,061 $5.22 Million
Q4 2021 Jan 19, 2022	SELL	$115.53 - $141.46 $297,489 - $364,259	-2,575 Reduced 5.47%	44,512 $6.27 Million
Q2 2021 Aug 09, 2021	SELL	$105.79 - $124.53 $5.61 Million - $6.61 Million	-53,053 Reduced 52.98%	47,087 $5.46 Million
Q1 2021 Apr 28, 2021	BUY	$108.84 - $128.23 $9.93 Million - $11.7 Million	91,217 Added 1022.27%	100,140 $12 Million

Q4 2020 Feb 08, 2021	SELL	$105.0 - $114.42 $10.5 Million - $11.4 Million	-99,822 Reduced 91.79%	8,923 $977,000
Q2 2020 Jul 22, 2020	BUY	$76.57 - $98.0 $7.6 Million - $9.72 Million	99,204 Added 1039.77%	108,745 $9.94 Million
Q1 2020 Apr 24, 2020	SELL	$62.82 - $91.86 $6.75 Million - $9.87 Million	-107,484 Reduced 91.85%	9,541 $753,000
Q4 2019 Jan 29, 2020	SELL	$78.51 - $87.4 $368,997 - $410,780	-4,700 Reduced 3.86%	117,025 $10.2 Million
Q3 2019 Oct 23, 2019	SELL	$81.84 - $88.74 $920,700 - $998,325	-11,250 Reduced 8.46%	121,725 $10.2 Million
Q2 2019 Jul 25, 2019	BUY	$72.88 - $85.0 $8.78 Million - $10.2 Million	120,425 Added 959.56%	132,975 $11.2 Million
Q1 2019 Apr 24, 2019	SELL	$66.22 - $80.06 $8.79 Million - $10.6 Million	-132,800 Reduced 91.37%	12,550 $1 Million
Q3 2018 Oct 10, 2018	SELL	$60.81 - $73.36 $60,810 - $73,360	-1,000 Reduced 0.68%	145,350 $10.7 Million
Q2 2018 Jul 18, 2018	BUY	$57.57 - $63.54 $189,981 - $209,682	3,300 Added 2.31%	146,350 $8.93 Million
Q1 2018 Apr 12, 2018	SELL	$56.27 - $63.62 $236,334 - $267,204	-4,200 Reduced 2.85%	143,050 $8.57 Million
Q4 2017 Jan 18, 2018	BUY	$53.68 - $57.47 $7.9 Million - $8.46 Million	147,250	147,250 $8.4 Million

Others Institutions Holding ABT

# of Institutions

3,129

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $181B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swarthmore Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Swarthmore Group Inc with notifications on news.

Account

Swarthmore Group Inc Abbott Laboratories Transaction History